Accendra Health, Inc. (NYSE: ACH) reported Q4 EPS of $0.21, $0.01 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $709 million versus the consensus estimate of $713.43 million.

GUIDANCE:

Accendra Health, Inc. sees FY2026 revenue of $2.55-2.65 billion, versus the consensus of $2.6 billion.

For earnings history and earnings-related data on Accendra Health, Inc. (ACH) click here.